Ovarian stimulation for fertility preservation in a woman with borderline serous ovarian tumor causing a large fluctuating subcutaneous fluid collection: a case report

Background: Fertility preservation in oncologic cases has increased exponentially during the last 15 years. Most of these cases occur in women with breast cancer or lymphoma. Rarely, the onco-fertility physician will have cases of young ovarian cancer patients who wish to cryopreserve their oocytes or embryos. Case: A previously undescribed presentation of a borderline serous ovarian tumor in a woman undergoing ovarian stimulation for fertility preservation. On the day of egg retrieval, a large subcutaneous fluid collection was noted. This fluid collection is possibly secondary to laparoscopic resection of the ovarian mass. Although, cancer recurrence has been noted at laparoscopic port entry sites and ovarian stimulation has been hypothesized to increase the risk of advancement of ovarian cancer cells, this is the first time in the medical literature that a supra-facial fluid collection occurred during gonadotropin stimulation, without ovarian hyperstimulation syndrome, in the context of ovarian malignancy. Our hypothesis is that during an operation before the stimulation cycle started, low malignant potential ovarian cells spread via the laparoscopy port to the subcutaneous space and grew in response to the gonadotropin stimulation. Conclusions: Being a borderline tumor, the fluid collection was self limited and did not re-occur with subsequent stimulations. However, in cases of frank ovarian malignacy and ovarian stimulation for fertility preservation cancer metastacis could occur to the sub-cutaneous space.

[1]  J. Varinot,et al.  Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG). , 2021, Gynecologic oncology.

[2]  B. D. de Carvalho,et al.  Ex vivo Retrieval of Mature Oocytes for Fertility Preservation in a Patient with Bilateral Borderline Ovarian Tumor , 2021, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

[3]  R. Ramanah,et al.  Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. , 2020, Journal of gynecology obstetrics and human reproduction.

[4]  Yulian Zhao,et al.  Fertility Preservation in Women: Indications and Options for Therapy. , 2020, Mayo Clinic proceedings.

[5]  F. Peccatori,et al.  Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin , 2020, Journal of Assisted Reproduction and Genetics.

[6]  E. Somigliana,et al.  Oocyte cryopreservation in two women with borderline ovarian tumor recurrence. , 2020, Journal of Assisted Reproduction and Genetics.

[7]  J. Leng,et al.  Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study. , 2020, Human reproduction.

[8]  A. Reignier,et al.  Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type. , 2018, Reproductive biomedicine online.

[9]  D. Radice,et al.  Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors. , 2016, American journal of obstetrics and gynecology.

[10]  M. Candiani,et al.  Fertility preservation in women with borderline ovarian tumours. , 2016, Cancer treatment reviews.

[11]  H. Maul,et al.  Isolated subcutaneous implantation of a borderline ovarian tumor: A case report and review of the literature. , 2016, World journal of clinical oncology.

[12]  T. Bruckner,et al.  Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women. , 2015, Reproductive biomedicine online.

[13]  Jae-Weon Kim,et al.  Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors) , 2014, International Journal of Gynecologic Cancer.

[14]  P. Morice,et al.  Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. , 2013, Human reproduction update.

[15]  S. Oehninger,et al.  Successful extracorporeal mature oocyte harvesting after laparoscopic oophorectomy following controlled ovarian hyperstimulation for the purpose of fertility preservation in a patient with borderline ovarian tumor , 2011, Journal of Assisted Reproduction and Genetics.

[16]  P. Devroey,et al.  Ex-vivo oocyte retrieval for fertility preservation. , 2011, Fertility and sterility.

[17]  R. Berretta,et al.  Incidence of port-site metastasis after laparoscopic management of borderline ovarian tumors: a series of 22 patients. , 2009, European journal of gynaecological oncology.

[18]  Seang Tan,et al.  Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. , 2007, Gynecologic oncology.

[19]  P. Morice,et al.  Port-Site Implantation After Laparoscopic Treatment of Borderline Ovarian Tumors , 2004, Obstetrics and gynecology.